FDC
Back to Balance Sheet
|
FDC Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹23 Cr | ₹17 Cr | ₹11 Cr | ₹16 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of FDC ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹23 Cr |
Mar2024 | ₹17 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹16 Cr |
Mar2021 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of FDC Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹23 Cr | 32.90 | |
Mar2024 | ₹17 Cr | 55.45 | |
Mar2023 | ₹11 Cr | -31.06 | |
Mar2022 | ₹16 Cr | 47.83 | |
Mar2021 | ₹11 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹7,447.3 Cr | -1.4% | -4.4% | -16.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,718.0 Cr | 1% | -0.2% | -13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,282.0 Cr | -2.7% | -2.2% | 17.6% | Stock Analytics | |
CIPLA | ₹125,351.0 Cr | -1.7% | 4.1% | -5.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,267.0 Cr | 1% | 1.3% | 4.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,952.0 Cr | 2.5% | 7.7% | -6.7% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | -1.4% |
-4.4% |
-16.9% |
SENSEX | 1.2% |
0.7% |
-1.5% |
You may also like the below Video Courses